"The team at Astera Cancer Care in East Brunswick will help you navigate the complex world of cancer treatment. From initial diagnosis to developing a complete cancer treatment plan, you will have a team of medical oncologists, radiation oncologists, and breast surgeons with you every step of the way. We also offer cancer support care and financial advocacy options as part of our commitment to our patients to provide an unparalleled, supported patient experience."

During the past decade, South Jersey Regional Cancer Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 8 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South Jersey Regional Cancer Center" #1 sponsor was "Radiation Therapy Oncology Group" with 28 trials, followed by "Fox Chase Cancer Center" with 5 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "AmpliMed Corporation" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South Jersey Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 36 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator and "Radiation Therapy Oncology Group" with 2 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "South Jersey Regional Cancer Center" are "Lung Cancer" (8 trials), "Prostate Cancer" (8 trials), "Head and Neck Cancer" (7 trials), "Brain and Central Nervous System Tumors" (4 trials) and "Radiation Toxicity" (4 trials). Many other conditions were trialed in "South Jersey Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "South Jersey Regional Cancer Center" are "Drug" (37 trials), "Radiation" (29 trials), "Procedure" (12 trials), "Biological" (8 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (29 trials), "cisplatin" (8 trials), "conventional surgery" (8 trials), "paclitaxel" (8 trials) and "filgrastim" (5 trials). Other intervention names were less common.

The vast majority of trials in "South Jersey Regional Cancer Center" are 38 trials for "All" genders, 6 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "South Jersey Regional Cancer Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in South Jersey Regional Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in South Jersey Regional Cancer Center, 10 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".